期刊文献+

补气活血汤治疗产后出血疗效与安全性探析 被引量:2

Analysis on the Curative Effect and Safety of Buqi Huoxue Decoction in Treating Postpartum Hemorrhage Based
下载PDF
导出
摘要 目的分析补气活血汤辨证治疗产后出血疗效与安全性。方法选取2017年9月—2018年9月收治的70例产后出血患者,依据随机抽签分组法将患者分为对照组与观察组各35例,分别应用常规西药与补气活血汤辨证治疗,评估2组疗效与安全性。结果观察组疗效优于对照组,不良反应发生率低于对照组,P <0. 05。结论补气活血汤辨证治疗产后出血患者,有助于改善症状,预防并发症发生,值得临床加大应用力度。 Objective To analyze the efficacy and safety of Buqi Huoxue decoction in treating postpartum hemorrhage.Methods From September 2017 to September 2018,70 patients with postpartum hemorrhage were treated in our hospital.According to the method of random drawing of lots,the patients were divided into control group(35 cases)and observation group(35 cases).The control group and the observation group were treated with routine western medicine and Buqi Huoxue decoction respectively.The efficacy and safety of the two groups were evaluated.Result The curative effect of the observation group was better than that of the control group,and the incidence of adverse reactions was lower than that of the control group(P<0.05).Conclusion The application of Buqi Huoxue decoction in treating postpartum hemorrhage patients is helpful to improve symptoms and prevent complications.It is worth increasing clinical application.
作者 杨红梅 YANG Hongmei(Department of Obstetrics and Gynecology,People's Hospital of Huairen Medical Group,Shanxi Province,Huairen 038300,china)
出处 《光明中医》 2019年第9期1365-1367,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 产后血晕 补气活血汤 产后出血 安全性 中医药疗法 postpartum anemic fainting Buqi Huoxue decoction postpartum hemorrhage safety therapy of TCM
  • 相关文献

参考文献5

二级参考文献58

  • 1朱广玲,朱秋玲,姜萍.卡贝缩宫素预防产后出血疗效分析[J].临床研究,2014,22(8):71-72. 被引量:2
  • 2黄芳.中药红花的现代药理研究进展[J].医学信息(医学与计算机应用),2014,0(25):674-674. 被引量:7
  • 3商艳红.子宫收缩乏力引起的产后出血预防和治疗[J].中国科技期刊数据库 医药,2016(9):114-115. 被引量:1
  • 4于冰,郝敏,王剑玲,刘宗梅.中药消炎止血胶囊治疗药物流产后阴道出血的临床研究[J].中国计划生育学杂志,2005,13(1):31-33. 被引量:15
  • 5Akinaga C,Uchizaki S,Kurita T,et al.Randomized doubleblind comparison of the effects of intramyometrial and intravenous oxytocin during elective cesarean section[J].J Obstet Gynaecol Res,2016,42(4):404-409.
  • 6Liu Y,Chen HX,Kang DL,et al.Influence of dexmedetomidine on incidence of adverse reactions introduced by hemabate in postpartum hemorrhage during cesarean section[J].Int J Clin Exp Med,2015,8(8):13776-13782.
  • 7Pakniat H,Khezri MB.The Effect of Combined Oxytocin-Misoprostol Versus Oxytocin and Misoprostol Alone in Reducing Blood Loss at Cesarean Delivery:A Prospective Randomized Double-Blind Study[J].J Obstet Gynaecol India,2015,65(6):376-381.
  • 8Boccolini CS,Perez-Escamilla R,Giugliani ER,et al.Inequities in milk-based prelacteal feedings in Latin America and the Caribbean:the role of cesarean section delivery[J].J Hum Lact,2015,31(1):89-98.
  • 9Pizzagalli F,Agasse J,Marpeau L.Carbetocin versus Oxytocin during caesarean section for preventing postpartum haemorrhage[J].Gynecol Obstet Fertil,2015,43(5):356-360.
  • 10Koen S,Snyman LC,Pattinson RC,et al.A randomised controlled trial comparing oxytocin and oxytocin+ergometrine for prevention of postpartum haemorrhage at caesarean section[J].S Afr Med J,2016,106(4):399-402.

同被引文献41

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部